![Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review) Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review)](https://www.spandidos-publications.com/article_images/ijmm/47/4/IJMM-47-04-04876-g00.jpg)
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review)
![Candesartan attenuates hypertension-associated pathophysiological alterations in the gut - ScienceDirect Candesartan attenuates hypertension-associated pathophysiological alterations in the gut - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332219309035-ga1.jpg)
Candesartan attenuates hypertension-associated pathophysiological alterations in the gut - ScienceDirect
![Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure | Circulation Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure | Circulation](https://www.ahajournals.org/cms/asset/331776ad-baeb-4976-bd63-4ad2960a69d5/11ff1.jpg)
Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure | Circulation
![Protein Kinase C-Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference | Hypertension Protein Kinase C-Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference | Hypertension](https://www.ahajournals.org/cms/asset/4d3788a9-1837-494b-ba22-69221c9476b8/9ff1.jpeg)
Protein Kinase C-Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference | Hypertension
![Candesartan and renal protection: more than blocking angiotensin type 1 receptor? - Kidney International Candesartan and renal protection: more than blocking angiotensin type 1 receptor? - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2043442005/2056058738/gr1.jpg)
Candesartan and renal protection: more than blocking angiotensin type 1 receptor? - Kidney International
![Basic properties of the losartan-and candesartan-AT 1-receptor interaction. | Download Scientific Diagram Basic properties of the losartan-and candesartan-AT 1-receptor interaction. | Download Scientific Diagram](https://www.researchgate.net/publication/258155719/figure/fig1/AS:669008244273158@1536515403124/Basic-properties-of-the-losartan-and-candesartan-AT-1-receptor-interaction.png)
Basic properties of the losartan-and candesartan-AT 1-receptor interaction. | Download Scientific Diagram
![Cells | Free Full-Text | Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular–Subventricular Zone | HTML Cells | Free Full-Text | Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular–Subventricular Zone | HTML](https://www.mdpi.com/cells/cells-08-01551/article_deploy/html/images/cells-08-01551-g008.png)
Cells | Free Full-Text | Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular–Subventricular Zone | HTML
![Mechanism of action of the antihypertensive drugs that act upon the... | Download Scientific Diagram Mechanism of action of the antihypertensive drugs that act upon the... | Download Scientific Diagram](https://www.researchgate.net/profile/Francisco-J-Silvestre-2/publication/5547910/figure/fig1/AS:280107970252800@1443794352588/Mechanism-of-action-of-the-antihypertensive-drugs-that-act-upon-the-renin-angiotensin.png)
Mechanism of action of the antihypertensive drugs that act upon the... | Download Scientific Diagram
![Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine](https://www.cebm.net/wp-content/uploads/2020/03/RAS2.jpg)
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
![Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension - Hjermitslev - 2017 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension - Hjermitslev - 2017 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/368dc1b5-b4f4-4f7f-920c-e59876b2cde5/bcpt12800-fig-0002-m.jpg)
Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension - Hjermitslev - 2017 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
![Therapeutics Initiative | [28] Angiotensin II Receptor Blockers – Their role in hypertension and congestive heart failure Therapeutics Initiative | [28] Angiotensin II Receptor Blockers – Their role in hypertension and congestive heart failure](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2010/08/28.gif)
Therapeutics Initiative | [28] Angiotensin II Receptor Blockers – Their role in hypertension and congestive heart failure
![REVIEW: COMBINED CANDESARTAN CILEXETIL AND PIOGLITAZONE HYDROCHLORIDE THERAPY IN METABOLIC SYNDROME | PharmaTutor REVIEW: COMBINED CANDESARTAN CILEXETIL AND PIOGLITAZONE HYDROCHLORIDE THERAPY IN METABOLIC SYNDROME | PharmaTutor](https://2.bp.blogspot.com/-augAW3cGOdo/VqhJdU4MhuI/AAAAAAAAFt0/dpZ9pdJgmRI/s1600/pt-art-2413-1.gif)
REVIEW: COMBINED CANDESARTAN CILEXETIL AND PIOGLITAZONE HYDROCHLORIDE THERAPY IN METABOLIC SYNDROME | PharmaTutor
Angiotensin II Receptor Blockers (ARBs): Indications, Side Effects, Mechanism of Action, Examples — EZmed
![REVIEW: COMBINED CANDESARTAN CILEXETIL AND PIOGLITAZONE HYDROCHLORIDE THERAPY IN METABOLIC SYNDROME | PharmaTutor REVIEW: COMBINED CANDESARTAN CILEXETIL AND PIOGLITAZONE HYDROCHLORIDE THERAPY IN METABOLIC SYNDROME | PharmaTutor](https://1.bp.blogspot.com/-pDkV8b46dK8/VqhJdE4Ac4I/AAAAAAAAFtw/ArX9lpEEOGo/s1600/pt-art-2413-2.gif)